2014
Asthma medication use during pregnancy, wheeze and estimated exposure to ambient nitrogen dioxide
Gent JF, Kezik JM, Hill ME, McKay LA, Holford TR, Leaderer BP, Bracken MB. Asthma medication use during pregnancy, wheeze and estimated exposure to ambient nitrogen dioxide. European Respiratory Journal 2014, 45: 538-540. PMID: 25537555, PMCID: PMC4331059, DOI: 10.1183/09031936.00161514.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAir Pollution, IndoorAsthmaFemaleHumansHypoxiaNitrogen DioxidePregnancyPregnancy ComplicationsRespiratory SoundsRisk FactorsYoung AdultConceptsAsthma medication useMedication usePregnant womenRisk of wheezePoor pulmonary functionAdverse health outcomesPregnant asthmaticsAsthma exacerbationsAsthma medicationsPerinatal complicationsPulmonary functionFetal growthHealth outcomesPregnancyNO2 exposureWheezeAsthmaMedicationsWomenAmbient nitrogen dioxideMothersMinimal effectExposureAsthmaticsExacerbation
1992
Role of biologic markers in epidemiologic studies of prenatal drug exposure: issues in study design.
Bracken M, Leaderer B, Belanger K. Role of biologic markers in epidemiologic studies of prenatal drug exposure: issues in study design. NIDA Research Monograph 1992, 117: 41-60. PMID: 1620210.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements